Biodegradable microcontainers as an oral drug delivery system for poorly soluble drugs. by Nielsen, Line Hagner et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
Biodegradable microcontainers as an oral drug delivery system for poorly soluble
drugs.
Nielsen, Line Hagner; Nagstrup, Johan; Keller, Stephan Sylvest; Gordon, Sarah; Østergaard, Jesper ;
Rades, Thomas; Müllertz, Anette; Boisen, Anja
Published in:
Proceedings of the 2013 AAPS Annual Meeting
Publication date:
2013
Link back to DTU Orbit
Citation (APA):
Nielsen, L. H., Nagstrup, J., Keller, S. S., Gordon, S., Østergaard, J., Rades, T., ... Boisen, A. (2013).
Biodegradable microcontainers as an oral drug delivery system for poorly soluble drugs. In Proceedings of the
2013 AAPS Annual Meeting
  
Biodegradable microcontainers as an oral drug delivery system for poorly soluble drugs 
Line Hagner Nielsen1, Johan Nagstrup2, Stephan Sylvest Keller2, Sarah Gordon3, Jesper Østergaard1, Thomas 
Rades1, Anette Müllertz1,4, Anja Boisen2 
 
1Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, 
Denmark 
2Department of Micro and Nanotechnology, Technical University of Denmark, Denmark 
3Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarland 
University, Saarbrücken, Germany 
4Bioneer:FARMA, Department of Pharmacy, Faculty of Health and Medical Sciences, University of 
Copenhagen, Copenhagen, Denmark 
 
PURPOSE: To fabricate microcontainers in biodegradable polylactic acid (PLLA) polymer films using hot 
embossing, and investigate the application of fabricated microcontainers as an oral drug delivery system for 
a poorly soluble drug.  
METHODS: For fabrication of the PLLA microcontainers, a film of PLLA was produced by spin coating. The 
film was heated above the polymer glass transition temperature (Tg), and a stamp was forced into the film. 
Following cooling of the film the stamp was removed, exposing the formed microcontainers. 
Microcontainers were filled with amorphous furosemide sodium salt (produced by spray drying) using a 
simplified version of a screen printing technique. An enteric-resistant lid of Eudragit L-100 was 
subsequently spray coated onto the cavity of the microcontainers. Release of amorphous furosemide salt 
from the coated microcontainers was investigated using a µ-Diss profiler. Release experiments were carried 
out in biorelevant gastric medium (pH 1.6) for 2 h, followed by 3 h in a biorelevant intestinal medium (pH 
6.5). Moreover, biorelevant flow through dissolution was also carried out in conjunction with UV imaging to 
visualize the release of amorphous furosemide salt from the coated microcontainers. 
RESULTS: Fabricated PLLA microcontainers had an inner diameter of 220 µm and a height of 100 µm. The 
screen printing technique was shown to be an optimized set-up to fill the microcontainers with drug. From 
the release experiments it was observed that the Eudragit layer prevented drug release in biorelevant 
gastric medium, while an immediate release of the amorphous furosemide salt was seen in the biorelevant 
intestinal medium. The same trend was observed in the UV imaging experiments –negligible drug release 
was observed in gastric medium, whereas following re-equilibration of the dissolution cell with the 
intestinal medium, a release of furosemide was observed after 1 min with an increased release after 5 min 
of dissolution. 
CONCLUSIONS: Biodegradable microcontainers were successfully fabricated and loaded with drug. Coating 
with Eudragit L-100 proved to be useful for protecting drug release from microcontainers in gastric 
medium, and facilitated an immediate release in the intestinal medium. The fabricated microcontainers 
therefore show considerable future potential as oral drug delivery systems. 
  
